Published by Josh White on 18th September 2024
(Sharecast News) - London-based life science company ValiRx has announced that its wholly-owned subsidiary, Inaphaea BioLabs, has entered into an evaluation and commercial use agreement with Spanish contract research organisation Xenopat.
URL: http://www.digitallook.com/dl/news/story/34563717/...